Medical Properties Trust (NYSE: MPW) reported Q2 FFO of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $99.8 million versus the consensus estimate of $101.72 million.

Based solely on the completed and pending acquisitions, development projects currently ongoing, which does not include the new $250 million commitment to Adeptus, and the completion of the MEDIAN sale leaseback transactions, per share Normalized FFO is expected to range between approximately $1.28 and $1.32 on an annual run-rate basis. This estimate does not include potential earnings from MPT’s equity investment in Capella.

For earnings history and earnings-related data on Medical Properties Trust (MPW) click here.